Anthropic white paper tests Claude on NMR structure elucidation against ChemDraw

The release details Claude's multimodal handling of raw spectral data, hand sketches, and database notations without pre-curated molecular graphs. David Kamber's tests compare outputs to ChemDraw predictions on standard small-molecule cases, focusing on peak assignment and isomer differentiation. No public accuracy percentages or dataset sizes appear in the document.

Existing ML retrosynthesis tools have shown uneven lab adoption due to sparse negative-result data and paywalled publications. Claude's step-by-step reasoning trace allows direct audit of bond assignments that statistical models often omit. This addresses the translation burden across 290 million CAS substances while the underlying training data gaps remain unchanged.

Operational impact centers on routine confirmation steps in medicinal chemistry workflows rather than full autonomous design. Integration with existing spectrometer exports could reduce manual cross-referencing time per compound. Next steps require quantified benchmarks on public NMR challenge sets before claims of workflow replacement.